Webster Thomas grad in the news

18 Mar

sutera

Proud momma Maria Sutera sent me this update on one of Webster’s own, Phil Sutera, who is making his mark in the field of science.

Phil, a 2010 Webster Thomas grad, is the first author of a cancer-focused research study, which was published in the January edition of the International Journal of Radiation Oncology, Biology, Physics.

Maria reported in her email that the study focused on “findings regarding stereotatic radiation therapy for oligometastic cancer (one to five metastases).” The clinical trial indicated that “a newer, more aggressive form of radiation therapy – stereotactic radiation – can extend long-term survival for some patients with stage-IV cancers while maintaining their quality of life.”

At least a half dozen news outlets have reported on the findings (you’ll see a few of those links below).  In addition to his recent publication, Phil recently received American Society of Radiation Oncology’s “Best of Astro” award for this research, chosen from more than 2,000 entries.

After graduating from Webster Thomas, Phil attended the University of Rochester, where he received dual Bachelor of Science degrees with highest distinction, in chemistry and neuroscience. He is currently studying at the University of Pittsburgh School of Medicine and will graduate in May. Philip hopes to match into a radiation oncology residency program.

“WCSD played an important role in Philip’s success,” Maria wrote, adding,

The teachers and staff at Webster laid a strong educational foundation, helped foster his scientific curiosity, advised him regarding his educational future, reinforced strong character traits, such as the desire to aid others (staff at Willink encouraged/recognized this with their annual Make a Difference Award, circa 2005), as well as awarded him various academic scholarships, which helped alleviate some educational expenses. We are extremely grateful and fortunate Phil had his start at Webster Central.

Click here to see the whole article, “Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer.” And here are a few links to some news reports about their findings:

https://medicalxpress.com/news/2019-02-stereotactic-feasible-oligometastatic-cancer.html

https://www.sciencedaily.com/releases/2019/01/190131101051.htm

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349603/

https://appliedradiationoncology.com/articles/study-high-dose-radiation-therapy-improves-long-term-survival-in-patients-with-stage-iv-cancers

* * *

email me  at missyblog@gmail.com“Like” this blog on Facebook and follow me on Twitter and Instagram

You can also get email notifications every time I post a new blog by using the “Follow Me” link on the right side of this page.

Edit This

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: